Antibodies under a microscope

DHC90702

Research Grade Ocrelizumab

Description

2H7, PR-070769 / PR070769 / R-1594 / RG-1594, CAS: 637334-45-3

Targets

B-lymphocyte surface antigen B1, Membrane-spanning 4-domains subfamily A member 1, MS4A1, Leukocyte surface antigen Leu-16, B-lymphocyte antigen CD20, Bp35, CD20

Isotype/Mimetic

IgG1-nd

Animal-Derived Biomaterials Used

None

Sequence Available

No

Original Discovery Method

Unknown

Original Discovery Information Provided On Datasheet

No

Antibody/Binder Origins

Unknown discovery source/method, In vitro recombinant expression